- Available history
- No dated observations
- Data captured
Dividend coverage
PLYX Dividend summary
Polaryx Therapeutics, Inc. (PLYX). What the retained company guidance contains and how many periods can be scored.
- Retained cash distributions: Value None reported.
- Retained history: Value Retained daily history from 2026-02-02 through 2026-06-30.
- Interpretation: Value The retained history is complete over that window and contains no such event; this is a completed zero, not missing normalization..
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |